Amgen Inc (LTS:0R0T)
$ 269.5 0 (0%) Market Cap: 160.64 Bil Enterprise Value: 212.02 Bil PE Ratio: 38.26 PB Ratio: 21.34 GF Score: 90/100

Q2 2023 Amgen Inc Earnings Call Transcript

Aug 03, 2023 / 08:30PM GMT
Release Date Price: $229.25 (-1.08%)
Operator

My name is Julianne, and I will be your conference facilitator today for Amgen's Second Quarter 2023 Financial Results Conference Call. (Operator Instructions)

I would now like to introduce Arvind Sood, Vice President of Investor Relations. Mr. Sood, you may now begin.

Arvind Sood
Amgen Inc. - VP of IR

Thank you, Julianne. Good afternoon, everyone, and welcome to our call to discuss our results for the second quarter. We continued down the path of strong unit volume growth during the quarter that led to an improved outlook for the rest of the year. This also sets the stage for growth longer term augmented by some meaningful pipeline updates, particularly with an oncology development.

Our Chairman and CEO, Bob Bradway, will lead the call with some prepared remarks, followed by a broader review of our performance by other members of our leadership team. You should have received a link to our slides that we posted. Through the course of our discussion, we will make some forward-looking statements and use non-GAAP financial measures to describe

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot